Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Intensity Therapeutics, Inc. INTS

Set alert

Price alert · INTS

All alert types
3.40 USD +0.06 +1.80%

At close · Oct 30

3.40 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
3.36 × 2
Ask
3.40 × 2
3.21 Day range 3.46
3.14 52-week range 33.00
YTD
-66.83%
1 year
-89.70%
Open
3.40
Prev close
3.34
Mkt cap
11.10M
Vol
16.12K
Avg vol
25.19K
EPS
-3.89
P/E
0.00
Div yield
0.00%
More statistics
Low
3.21
High
3.46
Forward P/E
-1.66
Beta
0.00
Short ratio
3.05
Inst. own
12.49%
Dividend
0.00
Ex-div date
Earnings
Aug 8, 2024
50-d avg
2.90
200-d avg
4.10
1y target
10.00

3M chart

Chart tools
Interval
1m5m15m30m

Signals (14)
NameDateAgo
MACD: Buy SignalOct 28, 20263 days ago
MACD: Sell SignalOct 16, 20262 weeks ago
MACD: Buy SignalOct 7, 20263 weeks ago
RSI: OversoldSep 30, 20261 month ago
MACD: Sell SignalSep 25, 20261 month ago
MACD: Buy SignalSep 22, 20261 month ago
MACD: Sell SignalAug 31, 20262 months ago
SMA: BearishAug 27, 20262 months ago
SMA: BearishAug 27, 20262 months ago
SMA: BullishAug 20, 20262 months ago
SMA: BullishAug 20, 20262 months ago
MACD: Buy SignalAug 20, 20262 months ago
SMA: BearishAug 11, 20262 months ago
SMA: BullishAug 10, 20262 months ago

Financial health

Altman Z-Score

-10.08 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B3 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 4

Valuation

P/E -1.2×
FY 2019: -3.8×FY 2020: -3.4×FY 2021: -2.6×FY 2022: -2.7×FY 2023: -6.2×FY 2024: -1.5×FY 2025: -1.2×
FY 2019 5y median -2.6× FY 2025
P/S 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 1.2×
FY 2019: 2.6×FY 2020: -13.0×FY 2021: -2.3×FY 2022: -1.3×FY 2023: 5.0×FY 2024: 8.4×FY 2025: 1.2×
FY 2019 5y median 1.2× FY 2025
P/FCF -1.5×
FY 2019: -4.6×FY 2020: -3.8×FY 2021: -3.0×FY 2022: -3.7×FY 2023: -9.1×FY 2024: -1.6×FY 2025: -1.5×
FY 2019 5y median -3.0× FY 2025
EV/EBITDA -0.2×
FY 2019: 56.5×FY 2020: -1.9×FY 2021: -2.3×FY 2022: -3.2×FY 2023: -5.7×FY 2024: -1.4×FY 2025: -0.2×
FY 2019 5y median -2.3× FY 2025
EV/Sales 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -66.3%
FY 2019: -21.8%FY 2020: -26.4%FY 2021: -33.6%FY 2022: -27.0%FY 2023: -11.0%FY 2024: -62.2%FY 2025: -66.3%
FY 2019 5y median -33.6% FY 2025

Profitability

Gross Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -97.7%
FY 2019: -67.9%FY 2020: 382.2%FY 2021: 90.9%FY 2022: 50.2%FY 2023: -80.1%FY 2024: -557.5%FY 2025: -97.7%
FY 2019 5y median -80.1% FY 2025
ROIC -99.9%
FY 2019: -71.0%FY 2020: -69.3%FY 2021: -216.9%FY 2022: 1324.6%FY 2023: -62.3%FY 2024: -542.7%FY 2025: -99.9%
FY 2019 5y median -99.9% FY 2025
ROA -82.3%
FY 2019: -58.1%FY 2020: -58.7%FY 2021: -151.4%FY 2022: -431.5%FY 2023: -60.9%FY 2024: -340.1%FY 2025: -82.3%
FY 2019 5y median -151.4% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 FY 2025
Operating Income 27.8%
FY 2019: 0.0%FY 2020: -9.7%FY 2021: -28.8%FY 2022: 5.8%FY 2023: -10.2%FY 2024: -99.4%FY 2025: 27.8%
FY 2019 FY 2025
EPS (diluted) 70.7%
FY 2019: 0.0%FY 2020: -12.0%FY 2021: -31.1%FY 2022: 4.3%FY 2023: 37.8%FY 2024: 15.2%FY 2025: 70.7%
FY 2019 FY 2025
Free Cash Flow 39.3%
FY 2019: 0.0%FY 2020: -21.6%FY 2021: -27.1%FY 2022: 19.8%FY 2023: -31.5%FY 2024: -111.2%FY 2025: 39.3%
FY 2019 FY 2025

Financial Health

Current Ratio 5.9×
FY 2019: 7.7×FY 2020: 7.0×FY 2021: 1.3×FY 2022: 0.2×FY 2023: 3.9×FY 2024: 1.9×FY 2025: 5.9×
FY 2019 5y median 1.9× FY 2025
Quick Ratio 5.9×
FY 2019: 7.7×FY 2020: 7.0×FY 2021: 1.3×FY 2022: 0.2×FY 2023: 3.9×FY 2024: 1.9×FY 2025: 5.9×
FY 2019 5y median 1.9× FY 2025
Debt / Equity 0.0×
FY 2019: 0.0×FY 2020: -0.3×FY 2021: -0.3×FY 2022: -0.3×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 1.0×
FY 2019: -12.1×FY 2020: 1.5×FY 2021: 0.3×FY 2022: -0.4×FY 2023: 0.8×FY 2024: 0.2×FY 2025: 1.0×
FY 2019 5y median 0.3× FY 2025
Interest Coverage 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: -478×FY 2022: -92.3×FY 2023: -27.3×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median -27.3× FY 2025

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31